HMGN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.178400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.223800E-01
Normal-vs-Stage2
1.675650E-01
Normal-vs-Stage3
1.925620E-01
Normal-vs-Stage4
3.463600E-01
Stage1-vs-Stage2
6.652200E-01
Stage1-vs-Stage3
3.263600E-01
Stage1-vs-Stage4
5.272200E-01
Stage2-vs-Stage3
3.510000E-01
Stage2-vs-Stage4
3.499600E-01
Stage3-vs-Stage4
4.946200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.519800E-01
Normal-vs-AfricanAmerican
2.015600E-01
Normal-vs-Asian
1.586630E-01
Caucasian-vs-AfricanAmerican
7.977400E-01
Caucasian-vs-Asian
4.091200E-01
AfricanAmerican-vs-Asian
7.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.446770E-01
Normal-vs-Female
3.285800E-01
Male-vs-Female
4.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.361200E-01
Normal-vs-Age(41-60Yrs)
3.582400E-01
Normal-vs-Age(61-80Yrs)
1.807230E-01
Normal-vs-Age(81-100Yrs)
1.612150E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.208200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.201000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.690020E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.032570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.380000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.701600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.391630E-01
Normal-vs-Daily Drinker
2.457400E-01
Normal-vs-Weekly Drinker
4.455000E-01
Normal-vs-Occasional Drinker
4.267400E-01
Normal-vs-Social Drinker
1.157010E-01
Non Drinker-vs-Daily Drinker
1.724050E-01
Non Drinker-vs-Weekly Drinker
7.918000E-01
Non Drinker-vs-Occasional Drinker
1.594750E-01
Non Drinker-vs-Social Drinker
4.840600E-01
Daily Drinker-vs-Weekly Drinker
6.438000E-01
Daily Drinker-vs-Occasional Drinker
7.894600E-01
Daily Drinker-vs-Social Drinker
5.145000E-01
Weekly Drinker-vs-Occasional Drinker
5.617400E-01
Weekly Drinker-vs-Social Drinker
8.840000E-01
Occasional Drinker-vs-Social Drinker
4.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.377400E-01
Normal-vs-Grade 2
7.124200E-01
Normal-vs-Grade 3
7.000200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.908800E-01
Grade 1-vs-Grade 3
3.242600E-01
Grade 1-vs-Grade 4
7.377400E-01
Grade 2-vs-Grade 3
4.822400E-01
Grade 2-vs-Grade 4
7.124200E-01
Grade 3-vs-Grade 4
7.000200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.248400E-02
Normal-vs-NonDiabetic
2.804200E-01
Diabetic-vs-NonDiabetic
2.279400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.561700E-02
Normal-vs-NoPancreatitis
2.762600E-01
Pancreatitis-vs-NoPancreatitis
7.566300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.720200E-01
Normal-vs-N1
1.687570E-01
N0-vs-N1
2.892800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.492200E-01
Normal-vs-TP53-NonMutant
3.079200E-01
TP53-Mutant-vs-TP53-NonMutant
9.481800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
